Surface Oncology IncNASDAQ:SURF
- LAST PRICE1.7600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.7600/ 17
- Ask / Lots1.8100/ 1
- Open / Previous Close0.0000 / 1.7600
- Day Range---
- 52 Week Range
- Volume3,154
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SURF |
|---|---|---|
| 09:32 ET | 3308 | 1.743 |
| 09:34 ET | 6344 | 1.72 |
| 09:36 ET | 5000 | 1.72 |
| 09:38 ET | 330 | 1.7048 |
| 09:39 ET | 2280 | 1.71 |
| 09:41 ET | 5580 | 1.73 |
| 09:43 ET | 3637 | 1.74 |
| 09:45 ET | 3815 | 1.7474 |
| 09:48 ET | 3779 | 1.76 |
| 09:50 ET | 3553 | 1.755 |
| 09:52 ET | 3422 | 1.755 |
| 09:54 ET | 200 | 1.77 |
| 09:56 ET | 4800 | 1.765 |
| 09:57 ET | 4100 | 1.76 |
| 09:59 ET | 6300 | 1.755 |
| 10:01 ET | 9099 | 1.76 |
| 10:03 ET | 1153 | 1.75 |
| 10:06 ET | 3920 | 1.7456 |
| 10:08 ET | 300 | 1.75 |
| 10:10 ET | 8682 | 1.76 |
| 10:12 ET | 700 | 1.76 |
| 10:14 ET | 9361 | 1.77 |
| 10:15 ET | 2000 | 1.77 |
| 10:17 ET | 9151 | 1.79 |
| 10:19 ET | 1700 | 1.79 |
| 10:21 ET | 2204 | 1.8 |
| 10:24 ET | 2150 | 1.79 |
| 10:26 ET | 400 | 1.785 |
| 10:28 ET | 5300 | 1.79 |
| 10:30 ET | 900 | 1.8 |
| 10:32 ET | 100 | 1.8 |
| 10:33 ET | 400 | 1.79 |
| 10:35 ET | 6300 | 1.8 |
| 10:37 ET | 1300 | 1.8 |
| 10:39 ET | 1319 | 1.7902 |
| 10:42 ET | 373 | 1.795 |
| 10:44 ET | 9493 | 1.78 |
| 10:46 ET | 2900 | 1.76 |
| 10:50 ET | 3013 | 1.74 |
| 10:51 ET | 1100 | 1.755 |
| 10:55 ET | 100 | 1.76 |
| 10:57 ET | 200 | 1.76 |
| 11:00 ET | 714 | 1.76 |
| 11:04 ET | 200 | 1.7479 |
| 11:06 ET | 5000 | 1.745 |
| 11:08 ET | 1600 | 1.75 |
| 11:09 ET | 200 | 1.75 |
| 11:18 ET | 300 | 1.745 |
| 11:20 ET | 100 | 1.75 |
| 11:22 ET | 1600 | 1.75 |
| 11:26 ET | 100 | 1.75 |
| 11:27 ET | 300 | 1.75 |
| 11:29 ET | 300 | 1.75 |
| 11:31 ET | 237 | 1.75 |
| 11:33 ET | 3797 | 1.75 |
| 11:36 ET | 663 | 1.75 |
| 11:38 ET | 300 | 1.75 |
| 11:40 ET | 200 | 1.75 |
| 11:42 ET | 500 | 1.75 |
| 11:44 ET | 2600 | 1.75 |
| 11:45 ET | 2700 | 1.76 |
| 11:49 ET | 168 | 1.755 |
| 11:51 ET | 600 | 1.755 |
| 11:54 ET | 1909 | 1.755 |
| 11:56 ET | 4400 | 1.76 |
| 11:58 ET | 118 | 1.755 |
| 12:00 ET | 100 | 1.76 |
| 12:02 ET | 400 | 1.7575 |
| 12:03 ET | 1605 | 1.75 |
| 12:07 ET | 200 | 1.75 |
| 12:09 ET | 500 | 1.7499 |
| 12:12 ET | 100 | 1.75 |
| 12:14 ET | 200 | 1.75 |
| 12:16 ET | 400 | 1.75 |
| 12:18 ET | 600 | 1.75 |
| 12:20 ET | 6700 | 1.75 |
| 12:21 ET | 784 | 1.75 |
| 12:23 ET | 7101 | 1.75 |
| 12:25 ET | 122305 | 1.76 |
| 12:27 ET | 100500 | 1.755 |
| 12:30 ET | 30749 | 1.7601 |
| 12:32 ET | 1200 | 1.77 |
| 12:34 ET | 309 | 1.771 |
| 12:36 ET | 100 | 1.775 |
| 12:38 ET | 600 | 1.77 |
| 12:41 ET | 2500 | 1.76 |
| 12:43 ET | 3400 | 1.765 |
| 12:45 ET | 300 | 1.765 |
| 12:48 ET | 1097 | 1.75 |
| 12:50 ET | 46100 | 1.76 |
| 12:52 ET | 100 | 1.75 |
| 12:54 ET | 300 | 1.755 |
| 12:56 ET | 200 | 1.76 |
| 12:59 ET | 25100 | 1.75 |
| 01:01 ET | 100 | 1.76 |
| 01:03 ET | 5616 | 1.76 |
| 01:06 ET | 30700 | 1.765 |
| 01:08 ET | 210 | 1.765 |
| 01:10 ET | 200 | 1.77 |
| 01:12 ET | 1304 | 1.78 |
| 01:14 ET | 600 | 1.78 |
| 01:15 ET | 25300 | 1.775 |
| 01:17 ET | 200 | 1.78 |
| 01:19 ET | 2390 | 1.78 |
| 01:21 ET | 890 | 1.775 |
| 01:24 ET | 5670 | 1.78 |
| 01:26 ET | 300 | 1.78 |
| 01:28 ET | 100 | 1.78 |
| 01:32 ET | 900 | 1.775 |
| 01:33 ET | 2583 | 1.775 |
| 01:35 ET | 3828 | 1.7775 |
| 01:37 ET | 2144 | 1.78 |
| 01:44 ET | 5682 | 1.775 |
| 01:46 ET | 2410 | 1.77 |
| 01:48 ET | 600 | 1.775 |
| 01:50 ET | 900 | 1.78 |
| 01:51 ET | 300 | 1.78 |
| 01:53 ET | 400 | 1.78 |
| 01:55 ET | 100 | 1.775 |
| 01:57 ET | 100 | 1.77 |
| 02:00 ET | 2500 | 1.77 |
| 02:02 ET | 7176 | 1.77 |
| 02:04 ET | 100 | 1.77 |
| 02:08 ET | 810 | 1.765 |
| 02:09 ET | 1000 | 1.77 |
| 02:11 ET | 300 | 1.77 |
| 02:15 ET | 200 | 1.765 |
| 02:18 ET | 1871 | 1.77 |
| 02:20 ET | 100 | 1.77 |
| 02:22 ET | 1100 | 1.765 |
| 02:24 ET | 800 | 1.765 |
| 02:26 ET | 1901 | 1.765 |
| 02:29 ET | 100 | 1.765 |
| 02:31 ET | 1400 | 1.765 |
| 02:33 ET | 600 | 1.765 |
| 02:36 ET | 22911 | 1.76 |
| 02:38 ET | 25500 | 1.77 |
| 02:40 ET | 1100 | 1.77 |
| 02:42 ET | 100 | 1.77 |
| 02:44 ET | 23484 | 1.785 |
| 02:45 ET | 300 | 1.785 |
| 02:49 ET | 100 | 1.785 |
| 02:51 ET | 2950 | 1.785 |
| 02:54 ET | 100 | 1.78 |
| 02:56 ET | 2700 | 1.775 |
| 02:58 ET | 9658 | 1.775 |
| 03:00 ET | 2642 | 1.76 |
| 03:02 ET | 745 | 1.75 |
| 03:03 ET | 650 | 1.75 |
| 03:05 ET | 4312 | 1.75 |
| 03:07 ET | 800 | 1.751 |
| 03:09 ET | 2800 | 1.755 |
| 03:12 ET | 700 | 1.755 |
| 03:14 ET | 400 | 1.755 |
| 03:16 ET | 7950 | 1.755 |
| 03:18 ET | 900 | 1.755 |
| 03:20 ET | 800 | 1.755 |
| 03:21 ET | 600 | 1.755 |
| 03:23 ET | 900 | 1.755 |
| 03:25 ET | 1654 | 1.75 |
| 03:27 ET | 500 | 1.755 |
| 03:30 ET | 900 | 1.75 |
| 03:32 ET | 4053 | 1.77 |
| 03:34 ET | 50100 | 1.77 |
| 03:36 ET | 1800 | 1.765 |
| 03:38 ET | 1400 | 1.77 |
| 03:39 ET | 2100 | 1.77 |
| 03:41 ET | 2000 | 1.77 |
| 03:43 ET | 700 | 1.77 |
| 03:45 ET | 990 | 1.765 |
| 03:48 ET | 8668 | 1.78 |
| 03:50 ET | 42262 | 1.78 |
| 03:52 ET | 8910 | 1.775 |
| 03:54 ET | 13097 | 1.77 |
| 03:56 ET | 5384 | 1.77 |
| 03:57 ET | 7742 | 1.775 |
| 03:59 ET | 8759 | 1.76 |
Jun 29, 2022
BRIEF-Surface Oncology Appoints Carsten Brunn To Board Of Directors, from 7:04AM ET on Wednesday Jun 29, 2022 by Thomson Reuters
7:04AM ET on Wednesday Jun 29, 2022 by Thomson ReutersSurface Oncology Appoints Carsten Brunn to Board of Directors, from 7:00AM ET on Wednesday Jun 29, 2022 by GlobeNewswire
7:00AM ET on Wednesday Jun 29, 2022 by GlobeNewswire
Jun 20, 2022
BRIEF-Surface Oncology Announces Publication Of New Study Demonstrating The Role Of The IL-27 Pathway In Hepatocellular Carcinoma, from 11:28AM ET on Monday Jun 20, 2022 by Thomson Reuters
11:28AM ET on Monday Jun 20, 2022 by Thomson ReutersSurface Oncology Announces Publication of New Study Demonstrating the Role of the IL-27 Pathway in Hepatocellular Carcinoma, from 10:05AM ET on Monday Jun 20, 2022 by GlobeNewswire
10:05AM ET on Monday Jun 20, 2022 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Surface Oncology Inc | 96.1M | -1.4x | --- |
Summit Therapeutics Inc | 97.4M | -1.0x | --- |
Dyadic International Inc | 89.0M | -7.2x | --- |
MyMD Pharmaceuticals Inc | 94.8M | -3.0x | --- |
Black Diamond Therapeutics Inc | 94.7M | -0.8x | --- |
Know Labs Inc | 97.9M | -2.9x | --- |
Company Information
Surface Oncology, Inc. is a clinical-stage, immuno-oncology company, which is focused on developing immunotherapies that target the tumor microenvironment. The Company is developing multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable an immunologic response and enhance outcomes for patients with cancer. The Company’s pipeline includes two wholly-owned clinical-stage programs targeting CD39 (SRF617) and IL-27 (SRF388), as well as a preclinical program focused on depleting tumor regulatory T cells through targeting CCR8 (SRF114). In addition, the Company has two partnerships with pharmaceutical companies, including a collaboration with Novartis targeting CD73 (NZV930; Phase 1) and a collaboration with GlaxoSmithKline targeting PVRIG (GSK4381562). Its novel cancer immunotherapies are designed to achieve a clinically meaningful and sustained anti-tumor response and may be used alone or in combination with other therapies.
Contact Information
- Headquarters
- 50 Hampshire St Fl 8CAMBRIDGE, MA, United States 02139-1548
- Phone
- 617-714-4096
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Denice Torres
- President, Chief Executive Officer, Director
- Robert Ross
- Chief Financial Officer, Treasurer
- Jessica Fees
- Senior Vice President - Legal, General Counsel, Secretary
- Theresa Boni
- Chief Scientific Officer
- Vito Palombella
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $96.1M |
|---|---|
Revenue (TTM) | $31.1M |
Shares Outstanding | 54.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.65 |
EPS | $-1.27 |
Book Value | $2.53 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | 3.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -175.83% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
